Virginia Kaklamani
Professor/Clinical · University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
Credentials: · · · ·
History
1999–2002- 1996–1999
- 1992–1996
National & Kapodistrian University of Athens
Research
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
New England Journal of Medicine · 2018 · 1,827 citations
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
New England Journal of Medicine · 2015 · 1,022 citations
Cancer Cell · 2019 · 840 citations
21 papers
21 papers
15 papers
9 papers
- KO
9 papers
9 papers
8 papers
7 papers
Grants
- 1997–2026
Mays Cancer Center at UT San Antonio Health Science Center
National Cancer Institute · P30
Project lead · $1.4M · University of Texas Hlth Science Center
- 2016–2021
San Antonio Breast Cancer Symposium
National Cancer Institute · R13
Contact PI · $50K · University of Texas Hlth Science Center
- 2011–2016
CTRC-AACR San Antonio Breast Cancer Symposium
National Cancer Institute · R13
Contact PI · $10K · University of Texas Hlth Science Center
Clinical trials
- 2024–2025
Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)
Principal investigator · Withdrawn · Early phase 1
Virginia G. Kaklamani
- 2019–2022
Imipramine on ER+ve and Triple Negative Breast Cancer
Principal investigator · Completed · Early phase 1
The University of Texas Health Science Center at San Antonio
- 2017–2020
Breast/Evaluation of Cryotherapy and TRPA1 Receptors in Chemotherapy Induced Neuropathy
Principal investigator · Completed
The University of Texas Health Science Center at San Antonio
- 2017–2020
Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients
Principal investigator · Withdrawn · Phase 2
The University of Texas Health Science Center at San Antonio